Virginia Beach student advances in Regeneron Science Talent Search
VIRGINIA BEACH, Va. (WAVY) — One Ocean Lakes High School student made the semi-finals of the prestigious Regeneron Science ...
Nasdaq23d
Regeneron Pharmaceuticals Reports Positive Phase 2 Results for Antithrombotic Antibodies REGN7508 and REGN9933 Targeting Factor XI
Regeneron Pharmaceuticals has announced positive Phase 2 results for two investigational monoclonal antibodies, REGN7508 and REGN9933, which target different domains of Factor XI to control ...
Page Six24d
‘90 Day Fiancé’ star David Murphey dead at 66
“90 Day Fiancé: Before the 90 Days” star David Murphey has died after a battle with liver cancer. “We are deeply saddened to announce that David Murphey, of Las Vegas, Nevada, passed away ...
New York Post24d
‘90 Day Fiancé’ star David Murphey dead at 66
“90 Day Fiancé” star David Murphey has died. He was 66. Murphey’s family confirmed his passing in a statement on his Instagram page Wednesday. “We are deeply saddened to announce that ...
The Hollywood Reporter24d
Warner Bros. Discovery CEO David Zaslav Sells $30M in Stock
By Alex Weprin Media & Business Writer Warner Bros. Discovery CEO David Zaslav has made his first significant sale of stock in the entertainment company since he led the merger of Discovery ...
FiercePharma24d
Regeneron's Eylea HD passes key test in retinal vein occlusion, teeing up 2025 FDA filing as Eylea threats mount
Since its August 2023 launch, Eylea HD has started making significant contributions to Regeneron's top line. During this year's third quarter, the drug generated $392 million in U.S. sales.
Portland Press Herald24d
David Mallett, iconic Maine singer-songwriter, dies at 73
Learn more. Friends and fans of Maine singer-songwriter David Mallett remembered him Wednesday for inspiring other musicians and writing songs that convey messages of hope and love. Mallett died ...
news.bloomberglaw25d
Regeneron, Allele Settle Covid Cocktail Patent Infringement Suit
Regeneron Pharmaceuticals Inc. settled a lawsuit accusing its Covid-19 “antibody cocktail” of infringing a California biotechnology company’s patent. Regeneron and Allele Biotechnology & ...
Benzinga.com25d
Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study
Regeneron's EYLEA HD met the primary endpoint in the Phase 3 QUASAR trial for macular edema following retinal vein occlusion. Vision gains with EYLEA HD every 8 weeks matched the current standard ...
Nasdaq25d
Regeneron Pharma: Phase 3 Trial With EYLEA HD 8 Mg Meets Primary Endpoint - Quick Facts
(RTTNews) - Regeneron Pharmaceuticals (REGN) announced the primary endpoint was met in the Phase 3 QUASAR trial investigating EYLEA HD or aflibercept injection 8 mg for the treatment of patients ...
Nasdaq25d
Regeneron announces primary endpoint met in Phase 3 QUASAR trial
Regeneron (REGN) Pharmaceuticals announced the primary endpoint was met in the Phase 3 QUASAR trial investigating EYLEA HD Injection 8 mg for the treatment of patients with macular edema following ...